Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure
AUTOR(ES)
Urbaczek, Ana Carolina, Ribeiro, Lívia Carolina de Abreu, Ximenes, Valdecir Farias, Afonso, Ana, Nogueira, Camila Tita, Generoso, Wesley Cardoso, Alberice, Juliana Vieira, Rudnicki, Martina, Ferrer, Renila, Fonseca, Luiz Marcos da, Costa, Paulo Inácio da
FONTE
Mem. Inst. Oswaldo Cruz
DATA DE PUBLICAÇÃO
09/09/2014
RESUMO
The hepatitis C virus (HCV) encodes approximately 10 different structural and non-structural proteins, including the envelope glycoprotein 2 (E2). HCV proteins, especially the envelope proteins, bind to cell receptors and can damage tissues. Endothelial inflammation is the most important determinant of fibrosis progression and, consequently, cirrhosis. The aim of this study was to evaluate and compare the inflammatory response of endothelial cells to two recombinant forms of the HCV E2 protein produced in different expression systems (Escherichia coli and Pichia pastoris). We observed the induction of cell death and the production of nitric oxide, hydrogen peroxide, interleukin-8 and vascular endothelial growth factor A in human umbilical vein endothelial cells (HUVECs) stimulated by the two recombinant E2 proteins. The E2-induced apoptosis of HUVECs was confirmed using the molecular marker PARP. The apoptosis rescue observed when the antioxidant N-acetylcysteine was used suggests that reactive oxygen species are involved in E2-induced apoptosis. We propose that these proteins are involved in the chronic inflammation caused by HCV.
Documentos Relacionados
- Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain▿
- Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses.
- Recombinant hepatitis C virus-envelope protein 2 interactions with low-density lipoprotein/CD81 receptors
- A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
- Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.